药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Gliquidone
MMDA
The risk or severity of adverse effects can be increased when MMDA is combined with Uric acid.
Gliquidone
Clenbuterol
The risk or severity of adverse effects can be increased when Clenbuterol is combined with Uric acid.
Gliquidone
Procaterol
The risk or severity of adverse effects can be increased when Procaterol is combined with Uric acid.
Gliquidone
Mephentermine
The risk or severity of adverse effects can be increased when Mephentermine is combined with Uric acid.
Gliquidone
Fenoterol
The risk or severity of adverse effects can be increased when Fenoterol is combined with Uric acid.
Gliquidone
Riociguat
Uric acid may increase the hypotensive activities of Riociguat.
Gliquidone
Fosphenytoin
The serum concentration of Uric acid can be decreased when it is combined with Fosphenytoin.
Gliquidone
Olodaterol
Uric acid may increase the hyperkalemic activities of Olodaterol.
Gliquidone
Lithium hydroxide
The serum concentration of Lithium hydroxide can be decreased when it is combined with Uric acid.
Gliquidone
Lithium carbonate
The serum concentration of Lithium carbonate can be decreased when it is combined with Uric acid.
Gliquidone
Lithium citrate
The serum concentration of Lithium citrate can be decreased when it is combined with Uric acid.
Gliquidone
Febuxostat
The serum concentration of the active metabolites of Uric acid can be increased when Uric acid is used in combination with Febuxostat.
Gliquidone
Regadenoson
Uric acid may decrease effectiveness of Regadenoson as a diagnostic agent.
Isocarboxazid
Testosterone undecanoate
Testosterone undecanoate may increase the hypertensive activities of Tyramine.
Isocarboxazid
Solriamfetol
The risk or severity of hypertension can be increased when Solriamfetol is combined with Tyramine.
Isocarboxazid
Esketamine
The risk or severity of hypertension can be increased when Esketamine is combined with Tyramine.
Isocarboxazid
Thyrotropin
The risk or severity of adverse effects can be increased when Tyramine is combined with Thyrotropin.
Isocarboxazid
Benzylthiouracil
The risk or severity of adverse effects can be increased when Tyramine is combined with Benzylthiouracil.
Isocarboxazid
Elcatonin
The risk or severity of adverse effects can be increased when Tyramine is combined with Elcatonin.
Isocarboxazid
Methylthiouracil
The risk or severity of adverse effects can be increased when Tyramine is combined with Methylthiouracil.